RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status

(2014) J. M. Cunningham et al.   Scientific Reports

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

(2013) Kathryn P. Pennington et al.   CLINICAL CANCER RESEARCH

Germline mutations in RAD51C in Jewish high cancer risk families

(2012) Anya Kushnir et al.   BREAST CANCER RESEARCH AND TREATMENT

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

(2012) K. De Leeneer et al.   BREAST CANCER RESEARCH AND TREATMENT

GermlineRAD51Cmutations in ovarian cancer susceptibility

(2012) F Coulet et al.   CLINICAL GENETICS

Mutation screening of RAD51C in high-risk breast and ovarian cancer families

(2012) Wenping Lu et al.   Familial Cancer

Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families

(2012) Ana Osorio et al.   HUMAN MOLECULAR GENETICS

Germline RAD51C mutations confer susceptibility to ovarian cancer

(2012) Chey Loveday et al.   NATURE GENETICS

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

(2011) Atocha Romero et al.   BREAST CANCER RESEARCH AND TREATMENT

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

(2011) Michelle W. Wong et al.   BREAST CANCER RESEARCH AND TREATMENT

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

(2011) Mikko Vuorela et al.   BREAST CANCER RESEARCH AND TREATMENT

RAD51C germline mutations in Chinese women with familial breast cancer

(2011) Zhiyuan Pang et al.   BREAST CANCER RESEARCH AND TREATMENT

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

(2011) Ella R. Thompson et al.   HUMAN MUTATION

Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair

(2011) Kumar Somyajit et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families

(2011) Jessica Clague et al.   PLoS One

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

(2011) T. Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

(2010) Yonglan Zheng et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutation of the RAD51C gene in a Fanconi anemia–like disorder

(2010) Fiona Vaz et al.   NATURE GENETICS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2

(2010) Eloïse Dray et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY